Evidence map›Paper›PMID 42173249›Full record

ArticleThe Journal of biological chemistry2026

An ART-fold Rhs toxin from Pluralibacter gergoviae defines Tne5, a novel family of NAD(P) glycohydrolases effectors.

Jonas B Desjardins, Martin Durrmeyer, Olivier Bornet, Eric Cascales

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonas B DesjardinsLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM - UMR7255), Aix-Marseille Univ, CNRS, UMR7255, Marseille, France.
Martin DurrmeyerLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM - UMR7255), Aix-Marseille Univ, CNRS, UMR7255, Marseille, France.
Olivier BornetNMR Facility, Institut de Microbiologie de la Méditerranée (IMM - UAR2044), Aix-Marseille Univ, CNRS, Marseille, France.
Eric CascalesLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM - UMR7255), Aix-Marseille Univ, CNRS, UMR7255, Marseille, France. Electronic address: cascales@imm.cnrs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The type VI secretion system (T6SS) is a widespread bacterial nanomachine that mediates interbacterial competition by delivering toxic effectors into neighboring cells. Among these, enzymes targeting nicotinamide adenine dinucleotide (NAD) cofactors and NAD phosphate (NAD(P)) are particularly potent because they rapidly disrupt redox homeostasis and central metabolism. Several families of T6SS-associated NAD(P)-consuming effectors (Tne1-Tne4) have been described. Here, we characterize a T6SS-associated Rearrangement hot spot toxin from Pluralibacter gergoviae. Competition assays show that P. gergoviae kills Escherichia coli in a T6SS-dependent manner. Heterologous production reveals that the Rearrangement hot spot C-terminal extension is toxic in the Escherichiacoli cytoplasm and that co-production with the protein encoded downstream neutralizes this activity. AlphaFold3 modeling predicts that the toxin adopts an ADP-ribosyltransferase-like α/β fold with a putative catalytic pocket accommodating NADH. By contrast to T6SS ART toxins described so far, the toxin does not inhibit transcription or translation but instead depletes NAD(P) in vitro and causes intracellular NAD depletion in intoxicated cells. Nuclear magnetic resonance analyses further show that the toxin hydrolyzes NAD

Indexed as

Bacterial ToxinsEscherichia coliModels, MolecularNADNAD+ NucleosidaseProtein FoldingType VI Secretion SystemsBacterial ToxinsNADNAD+ NucleosidaseType VI Secretion SystemsADP-ribosyltransferaseNADaseNAD(P) glycohydrolasePluralibacter gergoviaepolymorphic toxinRhstoxin–immunity pairtype VI secretion

Identifiers

PMID42173249
PMCPMC13285283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.